▁kid ne ys . ▁ ▁Av ail ability ▁ ▁PR RT ▁is ▁not ▁yet ▁widely ▁available , ▁with ▁various ▁radi oph arma ce ut ical s ▁at ▁different ▁stages ▁of ▁clin ical ▁tri als . ▁The ▁cost ▁of ▁small ▁volume ▁production ▁of ▁the ▁relevant ▁rad ion u cl ides ▁is ▁high . ▁The ▁cost ▁of ▁L ut ath era , ▁a ▁commercial ▁ 1 7 7 Lu - D OT AT ATE ▁product , ▁has ▁been ▁quoted ▁by ▁the ▁manufact urer ▁as ▁£ 7 1 , 5 0 0 ▁( € 8 0 , 0 0 0 ▁or ▁$ 9 4 , 0 0 0 ▁in ▁July ▁ 2 0 1 8 ) ▁for ▁ 4 ▁administr ations ▁of ▁ 7 . 4 ▁GB q . ▁ ▁United ▁States ▁ 1 7 7 Lu - D OT AT ATE ▁( intern ational ▁non prop ri et ary ▁name : ▁lut et ium ▁( 1 7 7 Lu ) ▁ox odot re ot ide ) ▁was ▁approved ▁by ▁the ▁F DA ▁in ▁early ▁ 2 0 1 8 , ▁for ▁treatment ▁of ▁g astro enter op an cre atic ▁ne uro end ocr ine ▁tum ors ▁( GE P - NET s ). ▁ ▁Europe ▁Mark eting ▁author isation ▁for ▁ 1 7 7 Lu - D OT AT ATE ▁was ▁granted ▁by ▁the ▁European ▁Medic ines ▁Agency ▁on ▁ 2 6 ▁September ▁ 2 0 1 7 . ▁ 9 0 Y - D OT AT OC ▁( intern ational ▁non prop ri